DUBLIN–(BUSINESS WIRE)–The “Cancer
Therapeutics and Supportive Care Drugs Market: Global Industry Analysis,
Trends, Market Size, and Forecasts up to 2025” report has been
added to ResearchAndMarkets.com’s offering.
The report on the global cancer therapeutics and supportive care drugs
market provides qualitative and quantitative analysis for the period
from 2017 to 2025.
The report predicts the global cancer therapeutics and supportive care
drugs market to grow with a CAGR of 9.4% over the forecast period from
2019-2025. The study on cancer therapeutics and supportive care drugs
market covers the analysis of the leading geographies such as North
America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
The report on cancer therapeutics and supportive care drugs market is a
comprehensive study and presentation of drivers, restraints,
opportunities, demand factors, market size, forecasts, and trends in
global cancer therapeutics and supportive care drugs market over the
period of 2017 to 2025. Moreover, the report is a collective
presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the
competitive rivalry, supplier and buyer positions in the market and
opportunities for the new entrants in the global cancer therapeutics and
supportive care drugs market over the period of 2017 to 2025. Further,
the Growth Matrix brings an insight into the investment areas that
existing or new market players can consider.
Report Findings
1) Drivers
- Innovations in the development of new drugs and therapies
- Increasing prevalence of cancerous patients
- Increasing demand for non-invasive therapies
2) Restraints
- The high cost of cancer drugs
3) Opportunities
- A large number of ongoing innovations for the treatment of cancer
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of
the cancer therapeutics and supportive care drugs market.
2. Complete coverage of all the segments in the cancer therapeutics and
supportive care drugs market to analyze the trends, developments in the
global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global
cancer therapeutics and supportive care drugs market. The company
profile includes analysis of product portfolio, revenue, SWOT analysis
and the latest developments of the company.
4. The Growth Matrix presents an analysis of the product segments and
geographies that market players should focus to invest, consolidate,
expand and/or diversify.
Key Topics Covered
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Cancer Therapeutics and Supportive Care Drugs Market Highlights
2.2. Cancer Therapeutics and Supportive Care Drugs Market Projection
2.3. Cancer Therapeutics and Supportive Care Drugs Market Regional
Highlights
3. Global Cancer Therapeutics and Supportive Care Drugs Market
Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter’s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drug Class
3.4.2. IGR-Growth Matrix Analysis by Distribution Channel
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cancer Therapeutics and Supportive Care
Drugs Market
4. Cancer Therapeutics and Supportive Care Drugs Market Macro
Indicator Analysis
5. Global Cancer Therapeutics and Supportive Care Drugs Market
by Drug Class
5.1. ESAS
5.2. Bisphosphonates
5.3. Opioids
5.4. G-CSFS
5.5. Antiemetics
5.6. NSAIDs
5.7. Other Drug Classes
6. Global Cancer Therapeutics and Supportive Care Drugs Market
by Distribution Channel
6.1. Hospital
6.2. Retail
7. Global Cancer Therapeutics and Supportive Care Drugs Market
by Region 2019-2025
7.1. North America
7.1.1. North America Cancer Therapeutics and Supportive Care Drugs
Market by Drug Class
7.1.2. North America Cancer Therapeutics and Supportive Care Drugs
Market by Distribution Channel
7.1.3. North America Cancer Therapeutics and Supportive Care Drugs
Market by Country
7.2. Europe
7.3. Asia-Pacific
7.4. RoW
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cancer Therapeutics and
Supportive Care Drugs Market
8.2. Companies Profiled
8.2.1. Takeda Pharmaceutical Company
8.2.2. Teva Pharmaceutical Industries
8.2.3. AbbVie Inc.
8.2.4. Sanofi S.A.
8.2.5. Eli Lilly
8.2.6. Novartis International AG
8.2.7. Pfizer Inc.
8.2.8. Johnson & Johnson
8.2.9. Bristol-Myers Squibb
8.2.10. Astellas Pharma Inc.
8.2.11. Other Companies
For more information about this report visit https://www.researchandmarkets.com/r/md6jcp
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Oncology
Drugs